SPHERE FLUIDICS
LIVE

Serial Number

79376665

Owner

Sphere Fluidics Limited

Attorney

MICHELLE E. TOCHTROP

Filing Date

Jul 11, 2023

Add to watchlist:

No watchlists yet
View on USPTO

SPHERE FLUIDICS Trademark

Serial Number: 79376665 • Registration: 7909880

SPHERE FLUIDICS is a trademark filed by Sphere Fluidics Limited on July 11, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Sphere Fluidics Limited (15 trademarks)

McClintock Building,

Entity Type: 99

Trademark Details

Filing Date

July 11, 2023

Registration Date

August 26, 2025

Published for Opposition

June 10, 2025

Goods & Services

Chemical preparations for medical purposes, namely, preparations for the treatment of cancer, cardiovascular, immunological, central nervous system, and metabolic diseases, genetic diseases, microbial infections, viral infections

Chemicals for use in industry and science; chemical reagents, other than for medical or veterinary purposes; chemical solutions, namely, gas soluble oils containing a surfactant, azo-dye, and biological reagents; surfactants for use in drug discovery and development, medical diagnostic applications, genetic research, synthetic biology and life sciences research namely, fluorinated or non-fluorinated surfactants, biocompatible surfactants, emulsifiers, dispersants, wetting agents; chemical coating agents for use in improving or enabling microfluidic processes namely, surfactants, polymers and other coating agents for enhancing fluid flow and controlling surface wettability in microfluidic devices and systems; chemical agents for de-emulsifying solutions, namely, demulsifiers, destabilizers, and phase-separating compounds, proteins and enzymes for breaking down emlusions; unprocessed polymers; pico droplets and microfluids for use in cell detection and molecular discovery being microscale fluid compartments encapsulated in an immiscible carrier fluid or microscale fluid compartments surrounding by an immiscible fluid shell in an immiscible carrier fluid for use in cell detection and molecular discovery, other than for medical or veterinary purposes

Scientific research and development; biopharmaceutical discovery being drug discovery and biopharmaceutical drug development; cell therapy engineering; scientific research and development, namely, bioproduction and synthetic biology, analysis and isolation

Laboratory apparatus and instruments, namely, pico droplet production instruments in the nature of microfluidic and emulsification instruments; Laboratory apparatus and instruments, namely, single cell analysis and isolation systems comprised of flow cells, droplet generators, segmented flow chips, single-cell encapsulation modules, and integrated microfluidic components; Laboratory apparatus and instruments, namely, cell engineering systems comprised of flow cells, droplet generators, segmented flow chips, single-cell encapsulation modules, and integrated microfluidic components; laboratory apparatus and instruments for use in cell detection and molecular discovery, namely, pico droplet production instruments in the nature of microfluidic and emulsification instruments; laboratory apparatus and instruments for use in cell detection and molecular discovery, namely, single cell analysis and isolation systems comprised of flow cells, droplet generators, segmented flow chips, single-cell encapsulation modules, and integrated microfluidic components; laboratory apparatus and instruments for use in cell detection and molecular discovery, namely, cell engineering systems comprised of flow cells, droplet generators, segmented flow chips, single-cell encapsulation modules, and integrated microfluidic components; laboratory apparatus and instruments for the analysis, retrieval and discovery of single cells, genes, or populations of proteins and molecules, contained in individual pico droplets, namely, pico droplet production instruments in the nature of microfluidic and emulsification instruments; laboratory apparatus and instruments for the analysis, retrieval and discovery of single cells, genes, or populations of proteins and molecules, contained in individual pico droplets, namely, single cell analysis and isolation systems comprised of flow cells, droplet generators, segmented flow chips, single-cell encapsulation modules, and integrated microfluidic components; laboratory apparatus and instruments for the analysis, retrieval and discovery of single cells, genes, or populations of proteins and molecules, contained in individual pico droplets, namely, cell engineering systems comprised of flow cells, droplet generators, segmented flow chips, single-cell encapsulation modules, and integrated microfluidic components; laboratory apparatus and instruments for the analysis of biomarkers, namely, pico droplet production instruments in the nature of microfluidic and emulsification instruments; laboratory apparatus and instruments for the analysis of biomarkers, namely, single cell analysis and isolation systems comprised of flow cells, droplet generators, segmented flow chips, single-cell encapsulation modules, and integrated microfluidic components; laboratory apparatus and instruments for the analysis of biomarkers, namely, cell engineering systems comprised of flow cells, droplet generators, segmented flow chips, single-cell encapsulation modules, and integrated microfluidic components; replacement parts and fittings in the nature of reflective mirrors for scientific use, tubing for scientific use, fluidic components namely, flow cells, controlled volume pumps and control valves for regulating the flow of gases and liquids, optical components namely, lasers for non-medical purposes, and light detectors, and electronic components namely, circuit boards, power supplies and electronic data processing apparatus for all the aforesaid goods

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 26, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 6, 2026 FICS
FINAL DISPOSITION PROCESSED
Mar 6, 2026 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 26, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 26, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 26, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 10, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jun 10, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 4, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 6, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
May 6, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 6, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
May 6, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 6, 2025 CNEA
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Apr 21, 2025 GNS1
CONTINUATION OF FINAL REFUSAL E-MAILED
Apr 21, 2025 GNCF
ACTION CONTINUING A FINAL - COMPLETED
Apr 21, 2025 CNCF
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 29, 2025 OPNX
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 18, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 18, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 18, 2025 ERFR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 11, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 11, 2025 OPNR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 28, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jan 28, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 28, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 28, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 28, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 28, 2025 COAR
NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 30, 2024 GNFN
FINAL REFUSAL E-MAILED
Sep 30, 2024 GNFR
FINAL REFUSAL WRITTEN
Sep 30, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 4, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 4, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 4, 2024 TROA
REFUSAL PROCESSED BY IB
Mar 27, 2024 RFNT
ATTORNEY REVIEW COMPLETED
Mar 4, 2024 ATRV
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 4, 2024 RFCS
REFUSAL PROCESSED BY MPU
Mar 4, 2024 RFRR
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Feb 27, 2024 CREV
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 10, 2024 RFCR
NON-FINAL ACTION WRITTEN
Feb 9, 2024 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Feb 6, 2024 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 20, 2024 RFCR
NON-FINAL ACTION WRITTEN
Jan 19, 2024 CNRT
ASSIGNED TO EXAMINER
Jan 17, 2024 DOCK
CORRECTION TRANSACTION RECEIVED FROM IB
Oct 15, 2023 CRCV
APPLICATION FILING RECEIPT MAILED
Aug 22, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 18, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 17, 2023 REPR